Hatfield Terry B 4

4 · KV PHARMACEUTICAL CO /DE/ · Filed Oct 16, 2007

Form 4

Period: 2007-10-11

Director

Transactions

Disposition to Issuer
Option to Purchase
2007-10-11−5,000→ 0 total
Exercise: $25.23Exp: 2009-06-29→ Class B Common Stock (5,000 underlying)
Award
Option to Purchase
2007-10-11+2,500→ 2,500 total
Exercise: $18.42Exp: 2009-09-10→ Class B Common Stock (2,500 underlying)
Disposition to Issuer
Option to Purchase
2007-10-11−2,500→ 0 total
Exercise: $17.85Exp: 2009-09-10→ Class B Common Stock (2,500 underlying)
Award
Option to Purchase
2007-10-11+5,000→ 5,000 total
Exercise: $25.25Exp: 2009-06-29→ Class B Common Stock (5,000 underlying)

Footnotes (3)

[F1]These two reported transactions involve an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 29, 2004 and provides for a vesting of 20% on date of grant and in 20% increments on each anniversary date thereafter.
[F2]These two reported transactions involve an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on September 10, 2004 and provides for a vesting of 20% on date of grant and in 20% increments on each anniversary date thereafter.
[F3]These two reported transactions involve an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on November 1, 2005 and provides for a vesting of 20% on date of grant and in 20% increments on each anniversary date thereafter.

Documents

2 files